| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,819 |
7,776 |
$837K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,596 |
4,229 |
$291K |
| 99199 |
Unlisted special service, procedure or report |
35,417 |
24,502 |
$184K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
989 |
640 |
$176K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
5,478 |
4,047 |
$142K |
| 99215 |
Prolong outpt/office vis |
1,245 |
967 |
$124K |
| 87428 |
|
2,232 |
1,612 |
$116K |
| 99443 |
|
1,785 |
1,354 |
$115K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,108 |
937 |
$85K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
903 |
755 |
$71K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,294 |
2,749 |
$60K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
662 |
544 |
$56K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
865 |
745 |
$51K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,509 |
1,225 |
$49K |
| 99442 |
|
903 |
772 |
$40K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,110 |
888 |
$38K |
| 99401 |
|
1,325 |
966 |
$37K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,814 |
1,408 |
$27K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
301 |
227 |
$23K |
| A4627 |
Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler |
672 |
555 |
$20K |
| 92587 |
|
796 |
736 |
$20K |
| 96127 |
|
3,465 |
2,402 |
$18K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,413 |
594 |
$18K |
| 92552 |
|
2,039 |
1,662 |
$17K |
| A7005 |
Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable |
773 |
648 |
$17K |
| 94664 |
|
1,194 |
1,002 |
$12K |
| 88738 |
|
1,942 |
1,639 |
$11K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
886 |
701 |
$9K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
296 |
224 |
$9K |
| 80061 |
Lipid panel |
598 |
512 |
$8K |
| 0071A |
|
61 |
54 |
$4K |
| 99173 |
|
2,686 |
2,254 |
$4K |
| 90651 |
|
137 |
131 |
$3K |
| 0072A |
|
42 |
40 |
$3K |
| D0145 |
Oral evaluation for a patient under three years of age |
77 |
68 |
$3K |
| 90686 |
|
1,756 |
1,517 |
$2K |
| E0570 |
Nebulizer, with compressor |
14 |
14 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
805 |
655 |
$2K |
| 90734 |
|
49 |
41 |
$2K |
| A7015 |
Aerosol mask, used with dme nebulizer |
1,091 |
871 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
61 |
58 |
$1K |
| 92567 |
|
787 |
726 |
$1K |
| 99417 |
Prolong home eval add 15m |
13 |
13 |
$1K |
| 87807 |
|
97 |
69 |
$1K |
| 90621 |
|
15 |
12 |
$1K |
| D1206 |
Topical application of fluoride varnish |
77 |
68 |
$1K |
| 85018 |
|
675 |
576 |
$941.39 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
138 |
80 |
$672.75 |
| 83655 |
|
67 |
59 |
$660.68 |
| 87634 |
|
15 |
13 |
$393.12 |
| 99441 |
|
12 |
12 |
$346.08 |
| 90474 |
|
15 |
15 |
$322.05 |
| 99051 |
|
19 |
12 |
$291.28 |
| 81002 |
|
138 |
99 |
$245.59 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
86 |
78 |
$192.37 |
| 96161 |
|
27 |
25 |
$106.11 |
| 90633 |
|
81 |
63 |
$103.92 |
| 90619 |
|
34 |
25 |
$11.55 |
| 91307 |
|
160 |
116 |
$11.02 |
| 36416 |
|
1,399 |
1,136 |
$10.50 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
76 |
57 |
$0.15 |
| 96160 |
|
16 |
16 |
$0.00 |
| 90670 |
|
60 |
55 |
$0.00 |
| 90680 |
|
15 |
15 |
$0.00 |